BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17652269)

  • 1. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts.
    Krauze MT; Noble CO; Kawaguchi T; Drummond D; Kirpotin DB; Yamashita Y; Kullberg E; Forsayeth J; Park JW; Bankiewicz KS
    Neuro Oncol; 2007 Oct; 9(4):393-403. PubMed ID: 17652269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy.
    Noble CO; Krauze MT; Drummond DC; Yamashita Y; Saito R; Berger MS; Kirpotin DB; Bankiewicz KS; Park JW
    Cancer Res; 2006 Mar; 66(5):2801-6. PubMed ID: 16510602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.
    Yamashita Y; Krauze MT; Kawaguchi T; Noble CO; Drummond DC; Park JW; Bankiewicz KS
    Neuro Oncol; 2007 Jan; 9(1):20-8. PubMed ID: 17018695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
    Saito R; Krauze MT; Noble CO; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    Neuro Oncol; 2006 Jul; 8(3):205-14. PubMed ID: 16723630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
    Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
    J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.
    Grahn AY; Bankiewicz KS; Dugich-Djordjevic M; Bringas JR; Hadaczek P; Johnson GA; Eastman S; Luz M
    J Neurooncol; 2009 Nov; 95(2):185-197. PubMed ID: 19466380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts.
    Chen PY; Ozawa T; Drummond DC; Kalra A; Fitzgerald JB; Kirpotin DB; Wei KC; Butowski N; Prados MD; Berger MS; Forsayeth JR; Bankiewicz K; James CD
    Neuro Oncol; 2013 Feb; 15(2):189-97. PubMed ID: 23262509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models.
    Zhang R; Saito R; Mano Y; Sumiyoshi A; Kanamori M; Sonoda Y; Kawashima R; Tominaga T
    Drug Deliv; 2016 Oct; 23(8):2780-2786. PubMed ID: 26330269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals.
    Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC
    Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models.
    Inoue T; Yamashita Y; Nishihara M; Sugiyama S; Sonoda Y; Kumabe T; Yokoyama M; Tominaga T
    Neuro Oncol; 2009 Apr; 11(2):151-7. PubMed ID: 18755917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
    Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T
    Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination Therapy of Intraperitoneal Rapamycin and Convection- Enhanced Delivery of Nanoliposomal CPT-11 in Rodent Orthotopic Brain Tumor Xenografts.
    Mendiburu-Eliçabe M; Gil-Ranedo J
    Curr Cancer Drug Targets; 2015; 15(4):352-62. PubMed ID: 25714699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.
    Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors.
    Noble CO; Krauze MT; Drummond DC; Forsayeth J; Hayes ME; Beyer J; Hadaczek P; Berger MS; Kirpotin DB; Bankiewicz KS; Park JW
    Nanomedicine (Lond); 2014 Jul; 9(14):2099-108. PubMed ID: 24494810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation.
    Dickinson PJ; LeCouteur RA; Higgins RJ; Bringas JR; Roberts B; Larson RF; Yamashita Y; Krauze M; Noble CO; Drummond D; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
    J Neurosurg; 2008 May; 108(5):989-98. PubMed ID: 18447717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.
    Louis N; Liu S; He X; Drummond DC; Noble CO; Goldman S; Mueller S; Bankiewicz K; Gupta N; Hashizume R
    J Neurooncol; 2018 Feb; 136(3):475-484. PubMed ID: 29170909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging.
    Saito R; Bringas JR; McKnight TR; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Apr; 64(7):2572-9. PubMed ID: 15059914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy.
    Drummond DC; Noble CO; Guo Z; Hong K; Park JW; Kirpotin DB
    Cancer Res; 2006 Mar; 66(6):3271-7. PubMed ID: 16540680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
    Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
    Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.